DAVID J. MAZZO - Corporate Board Profile

EyePoint Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2008-10-15	Dr. Mazzo is President and Chief Executive Officer, and a director, of Regado Biosciences, Inc., an antidote drug systems discovery and development company... Dr. Mazzo previously held management positions in several international pharmaceutical companies.
2009-10-13	Dr. Mazzo is President and Chief Executive Officer, and a director, of Regado Biosciences, Inc., an antidote drug systems discovery and development company... Dr. Mazzo previously held management positions in several international pharmaceutical companies.
2010-10-25	Dr. Mazzo’s extensive experience as an executive officer and director in the life sciences industry, his PhD in analytical chemistry and his broad scientific and managerial background provide him expertise in the oversight of companies in this sector.
2011-10-25	Dr. Mazzo’s extensive experience as an executive officer and director in the life sciences industry, his understanding of the strategic and regulatory environment in which pSivida conducts its business, his lengthy track record in global product development, his PhD in analytical chemistry and his broad scientific and managerial background provide him expertise in the oversight of companies in this sector and the ability to guide such companies through varying operating climates.
2012-10-25	Dr. Mazzo’s extensive experience as an executive officer and director in the life sciences industry, his understanding of the strategic and regulatory environment in which pSivida conducts its business, his lengthy track record in global product development, his PhD in analytical chemistry and his broad scientific and managerial background provide him expertise in the oversight of companies in this sector and the ability to guide such companies through varying operating climates.
2013-10-25	Dr. Mazzo’s extensive experience as an executive officer and director in the life sciences industry, his understanding of the strategic and regulatory environment in which pSivida conducts its business, his lengthy track record in global product development, his PhD in analytical chemistry and his broad scientific and managerial background provide him expertise in the oversight of companies in this sector and the ability to guide such companies through varying operating climates.
2014-10-24	Dr. Mazzo holds a B.A. degree in Honors (Interdisciplinary Humanities) and a B.S. degree in Chemistry from Villanova University, as well as an M.S. degree in Chemistry and a Ph.D. degree in Analytical Chemistry from the University of Massachusetts (Amherst).
2015-10-23	Dr. Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr. Mazzo received his M.S. in chemistry and his Ph.D. degree in analytical chemistry from the University of Massachusetts, Amherst.
2017-05-15	David J. Mazzo 405,500 shares 1.02% beneficial ownership.
2017-11-13	Dr. Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr. Mazzo received his M.S. in chemistry and his Ph.D. degree in analytical chemistry from the University of Massachusetts, Amherst.
2018-05-11	David J. Mazzo 472,500 *

Data sourced from SEC filings. Last updated: 2026-03-05